652 related articles for article (PubMed ID: 24152895)
1. Cyclodextrin based nanosponges for pharmaceutical use: a review.
Tejashri G; Amrita B; Darshana J
Acta Pharm; 2013 Sep; 63(3):335-58. PubMed ID: 24152895
[TBL] [Abstract][Full Text] [Related]
2. Cyclodextrin-based nanosponges as promising carriers for active pharmaceutical ingredient.
Jawaharlal S; Subramanian S; Palanivel V; Devarajan G; Veerasamy V
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23597. PubMed ID: 38037252
[TBL] [Abstract][Full Text] [Related]
3. The application of nanosponges to cancer drug delivery.
Trotta F; Dianzani C; Caldera F; Mognetti B; Cavalli R
Expert Opin Drug Deliv; 2014 Jun; 11(6):931-41. PubMed ID: 24811423
[TBL] [Abstract][Full Text] [Related]
4. Ester-Based Hydrophilic Cyclodextrin Nanosponges for Topical Ocular Drug Delivery.
Hayiyana Z; Choonara YE; Makgotloe A; du Toit LC; Kumar P; Pillay V
Curr Pharm Des; 2016; 22(46):6988-6997. PubMed ID: 27981908
[TBL] [Abstract][Full Text] [Related]
5. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
Cirri M; Bragagni M; Mennini N; Mura P
Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
[TBL] [Abstract][Full Text] [Related]
6. Cyclodextrin-based nanosponges for the targeted delivery of the anti-restenotic agent DB103: A novel opportunity for the local therapy of vessels wall subjected to percutaneous intervention.
Coviello V; Sartini S; Quattrini L; Baraldi C; Gamberini MC; La Motta C
Eur J Pharm Biopharm; 2017 Aug; 117():276-285. PubMed ID: 28456606
[TBL] [Abstract][Full Text] [Related]
7. Nanosponges -A Promising Novel Drug Delivery System.
Pandey P; Purohit D; Dureja H
Recent Pat Nanotechnol; 2018; 12(3):180-191. PubMed ID: 30251614
[TBL] [Abstract][Full Text] [Related]
8. Novel cyclodextrin nanosponges for delivery of calcium in hyperphosphatemia.
Shende P; Deshmukh K; Trotta F; Caldera F
Int J Pharm; 2013 Nov; 456(1):95-100. PubMed ID: 23954237
[TBL] [Abstract][Full Text] [Related]
9. Controlling drug nanoparticle formation by rapid precipitation.
D'Addio SM; Prud'homme RK
Adv Drug Deliv Rev; 2011 May; 63(6):417-26. PubMed ID: 21565233
[TBL] [Abstract][Full Text] [Related]
10. Cyclodextrin-based nanosponges: effective nanocarrier for tamoxifen delivery.
Torne S; Darandale S; Vavia P; Trotta F; Cavalli R
Pharm Dev Technol; 2013; 18(3):619-25. PubMed ID: 22235935
[TBL] [Abstract][Full Text] [Related]
11. Nanosponge Carriers- An Archetype Swing in Cancer Therapy: A Comprehensive Review.
Osmani RA; Hani U; Bhosale RR; Kulkarni PK; Shanmuganathan S
Curr Drug Targets; 2017; 18(1):108-118. PubMed ID: 26424399
[TBL] [Abstract][Full Text] [Related]
12. The ascension of nanosponges as a drug delivery carrier: preparation, characterization, and applications.
Tiwari K; Bhattacharya S
J Mater Sci Mater Med; 2022 Mar; 33(3):28. PubMed ID: 35244808
[TBL] [Abstract][Full Text] [Related]
13. Cyclodextrin-based nanogels for pharmaceutical and biomedical applications.
Moya-Ortega MD; Alvarez-Lorenzo C; Concheiro A; Loftsson T
Int J Pharm; 2012 May; 428(1-2):152-63. PubMed ID: 22388054
[TBL] [Abstract][Full Text] [Related]
14. Drug-Encapsulated Cyclodextrin Nanosponges.
Tannous M; Caldera F; Hoti G; Dianzani U; Cavalli R; Trotta F
Methods Mol Biol; 2021; 2207():247-283. PubMed ID: 33113141
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Patent Review on β-cyclodextrin Cross-linked Nanosponges for Multiple Applications.
Pawar S; Shende P
Recent Pat Nanotechnol; 2020; 14(1):75-89. PubMed ID: 31161998
[TBL] [Abstract][Full Text] [Related]
16. Nanosponge formulations as oxygen delivery systems.
Cavalli R; Akhter AK; Bisazza A; Giustetto P; Trotta F; Vavia P
Int J Pharm; 2010 Dec; 402(1-2):254-7. PubMed ID: 20888402
[TBL] [Abstract][Full Text] [Related]
17. Nanosponge Approach -A Plethora of Opportunities as a Promising Nanocarrier for Novel Drug Delivery.
Bhavin SE; Anuradha G
Recent Pat Nanotechnol; 2022; 16(4):271-282. PubMed ID: 34303335
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery.
Cirpanli Y; Bilensoy E; Lale Doğan A; Caliş S
Eur J Pharm Biopharm; 2009 Sep; 73(1):82-9. PubMed ID: 19442723
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrin containing biodegradable particles: from preparation to drug delivery applications.
Zafar N; Fessi H; Elaissari A
Int J Pharm; 2014 Jan; 461(1-2):351-66. PubMed ID: 24342710
[TBL] [Abstract][Full Text] [Related]
20. Nanosponges - a completely new nano-horizon: pharmaceutical applications and recent advances.
Ahmed RZ; Patil G; Zaheer Z
Drug Dev Ind Pharm; 2013 Sep; 39(9):1263-72. PubMed ID: 22681585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
